{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"EP Edge Journal Watch: Cardiac Electrophysiology Research","title":"EP Edge® Journal Watch 44, November 2026: AF Ablation Endpoints, Conduction System Pacing and Exercise","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/1ecfa1f6\"></iframe>","width":"100%","height":180,"duration":1656,"description":"EP Edge® Journal Watch 44, November 2026: AF Ablation Endpoints, Conduction System Pacing and Exercise\nWhat should count as successful atrial fibrillation ablation? Can shorter follow-up reliably assess treatment effectiveness? How might conduction system pacing, atrial physiology, and exercise intensity influence the way we evaluate and manage arrhythmia risk?\nIn Issue 44 of EP Edge® Journal Watch, Dr. Sharma examines five featured publications in depth, explaining their rationale, methods, findings, statistical interpretation, limitations, and practical implications. The episode also provides brief assessments of the remaining publications, with comprehensive analyses and infographics available in the newsletter.\nDesigned for electrophysiologists, cardiologists, trainees, and clinicians interested in cardiovascular research, this episode connects the evidence to the decisions it can reasonably inform.\nFEATURED DISCUSSIONS\nAF ablation endpoints: why six minutes, and why two months of blanking?\nWang and colleagues’ Academic Research Consortium report proposes a framework for evaluating atrial fibrillation ablation effectiveness and safety. We examine the rationale behind the six-minute recurrence threshold, the two-month blanking period, and the distinction between device detection and adjudicated trial outcomes. The discussion also covers AF burden, medication exposure, monitoring intensity, follow-up duration, and safety assessment for emerging technologies.\nWang PJ, et al. Atrial Fibrillation Ablation Effectiveness End Points, Safety End Points, and Trial Design: Academic Research Consortium Initiative Endorsed by the Heart Rhythm Society. Circulation: Arrhythmia and Electrophysiology. 2026.\nDOI: https://doi.org/10.1161/CIRCEP.126.015082\nCan six-month outcomes predict twelve-month ablation success?\nAndrade and colleagues analyze 905 patients from four prospective studies. Agreement between shorter and conventional endpoints was high, but sensitivity for...","thumbnail_url":"https://img.transistorcdn.com/C7iPWVsHlGRm13syn3X4eXGLcqOXyzcuH5XmVutqgHc/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9jMzFi/ZTYxOTI1M2U4NGRj/OGZmZjBhMDFlMjFm/NDQwMC5wbmc.webp","thumbnail_width":300,"thumbnail_height":300}